Personal information

Emails & domains

Verified email domains

Websites & social links

MONASH UNIVERSITY profile page

Other IDs

Scopus Author ID: 56531295900
Scopus Author ID: 56531295900

Activities

Collapse all

Employment (3)

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

Employment
Source: Self-asserted source
Rachel Wong

MONASH UNIVERSITY: Clayton, AU

Employment
Source: check_circle
Monash University

Eastern Health: Box Hill, VIC, AU

Employment
Source: Self-asserted source
Rachel Wong

Works (50 of 69)

Items per page:
Page 1 of 2

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial

Nature Medicine
2025-03-07 | Journal article
DOI: 10.1038/s41591-025-03579-w
Contributors: Jeanne Tie; Yuxuan Wang; Serigne N. Lo; Kamel Lahouel; Joshua D. Cohen; Rachel Wong; Jeremy D. Shapiro; Samuel J. Harris; Adnan Khattak; Matthew E. Burge et al.
Source: check_circle
Crossref

Data from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6531279.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Data from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.c.6531279
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 1 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483950.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 1 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483950
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 2 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483947
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 2 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483947.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 3 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483944.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supp Figure 3 from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483944
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supplementary Legend from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483941.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supplementary Legend from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483941
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supplementary Tables from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483938
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Supplementary Tables from Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

2023-03-31 | Preprint
DOI: 10.1158/1078-0432.22483938.v1
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry

European Journal of Cancer
2022-10 | Journal article
DOI: 10.1016/j.ejca.2022.06.042
Contributors: Jordan Santucci; Mark Tacey; Benjamin Thomson; Michael Michael; Rachel Wong; Julia Shapiro; Ross Jennens; Kate Clarke; Sharon Pattison; Matthew Burge et al.
Source: check_circle
Crossref

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

Cancers
2022-08-26 | Journal article
DOI: 10.3390/cancers14174131
Contributors: Belinda Lee; Lucy Gately; Sheau Wen Lok; Ben Tran; Margaret Lee; Rachel Wong; Ben Markman; Kate Dunn; Vanessa Wong; Matthew Loft et al.
Source: check_circle
Crossref

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

New England Journal of Medicine
2022-06-16 | Journal article
DOI: 10.1056/NEJMoa2200075
Contributors: Jeanne Tie; Joshua D. Cohen; Kamel Lahouel; Serigne N. Lo; Yuxuan Wang; Suzanne Kosmider; Rachel Wong; Jeremy Shapiro; Margaret Lee; Sam Harris et al.
Source: check_circle
Crossref

Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer

Current Problems in Cancer
2022-04 | Journal article
DOI: 10.1016/j.currproblcancer.2021.100793
Contributors: A Jalali; G Gard; S Banks; C Dunn; HL Wong; R Wong; M Lee; L Gately; M Loft; JD Shapiro et al.
Source: check_circle
Crossref

Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia

Internal Medicine Journal
2022-01 | Journal article
DOI: 10.1111/imj.15094
Contributors: Amy Body; Rachel Wong; Jeremy Shapiro; Azim Jalali; Sue‐Anne McLachlan; Sumitra Ananda; Lara Lipton; Prasad Cooray; Peter Gibbs; Belinda Lee et al.
Source: check_circle
Crossref

Real‐world outcomes for neoadjuvant capecitabine versus infusional 5‐fluorouracil in the treatment of locally advanced rectal cancer

Internal Medicine Journal
2021-08 | Journal article
DOI: 10.1111/imj.15045
Contributors: Matthew Loft; Hui‐Li Wong; Suzanne Kosmider; Margaret Lee; Jeanne Tie; Rachel Wong; Ian T. Jones; Matthew Croxford; Malcolm Steel; Ian Faragher et al.
Source: check_circle
Crossref

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study

PLOS Medicine
2021-05-03 | Journal article
DOI: 10.1371/journal.pmed.1003620
Contributors: Jeanne Tie; Yuxuan Wang; Joshua Cohen; Lu Li; Wei Hong; Michael Christie; Hui Li Wong; Suzanne Kosmider; Rachel Wong; Benjamin Thomson et al.
Source: check_circle
Crossref

Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study

Clinical Cancer Research
2021-04-15 | Journal article
DOI: 10.1158/1078-0432.CCR-20-2714
Contributors: Jennifer Mooi; Fiona Chionh; Peter Savas; Jessica Da Gama Duarte; Geoffrey Chong; Stephen Brown; Rachel Wong; Timothy J. Price; Alysson Wann; Effie Skrinos et al.
Source: check_circle
Crossref

Characteristics and outcomes of participants in colorectal cancer biomarker trials versus a real-world cohort

Acta Oncologica
2021-04-03 | Journal article
DOI: 10.1080/0284186X.2020.1862907
Contributors: Siavash Foroughi; Hui-li Wong; Jeanne Tie; Rachel Wong; Margaret Lee; Belinda Lee; Ian Jones; Iain Skinner; Antony W. Burgess; Peter Gibbs
Source: check_circle
Crossref

Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)

Radiotherapy and Oncology
2021-02 | Journal article
DOI: 10.1016/j.radonc.2020.10.012
Contributors: Sweet Ping Ng; Julie Chu; Sarat Chander; Mathias Bressel; Joseph McKendrick; Rachel Wong; Malcolm Steel; William K. Murray; Trevor Leong; Alexander Heriot et al.
Source: check_circle
Crossref

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

International Journal of Cancer
2021-02-15 | Journal article
DOI: 10.1002/ijc.33312
Contributors: Jeanne Tie; Joshua D. Cohen; Serigne N. Lo; Yuxuan Wang; Lu Li; Michael Christie; Margaret Lee; Rachel Wong; Suzanne Kosmider; Iain Skinner et al.
Source: check_circle
Crossref

Resection of colorectal cancer liver metastases in older patients

ANZ Journal of Surgery
2020 | Journal article
DOI: 10.1111/ans.15750
EID:

2-s2.0-85079730576
Contributors: Kumari, S.; Semira, C.; Lee, M.; Lee, B.; Wong, R.; Nott, L.; Shapiro, J.; Gibbs, P.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia

Internal Medicine Journal
2020 | Journal article
DOI: 10.1111/imj.14288
EID:

2-s2.0-85079205341
Contributors: Delahunty, R.; Lee, M.; Wong, H.-L.; Johns, J.; Mckendrick, J.; Lee, B.; Kosmider, S.; Cooray, P.; Ananda, S.; Desai, J. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

PharmacoEconomics
2020-11-17 | Journal article
DOI: 10.1007/s40273-020-00951-1
Contributors: Koen Degeling; Hui-Li Wong; Hendrik Koffijberg; Azim Jalali; Jeremy Shapiro; Suzanne Kosmider; Rachel Wong; Belinda Lee; Matthew Burge; Jeanne Tie et al.
Source: check_circle
Crossref

Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancer

Growth Factors
2020-07-03 | Journal article
DOI: 10.1080/08977194.2021.1878166
Contributors: Siavash Foroughi; Ryan A. Hutchinson; Hui-li Wong; Michael Christie; Ahida Batrouney; Rachel Wong; Margaret Lee; Jeanne Tie; Antony Wilks Burgess; Peter Gibbs
Source: check_circle
Crossref

Body Composition Adjusted Dosing of Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Does Not Predict Toxicity Compared to Body Surface Area Dosing

Nutrition and Cancer
2019 | Journal article
DOI: 10.1080/01635581.2018.1542011
EID:

2-s2.0-85061256200
Contributors: Freckelton, J.; Croagh, D.; Holt, D.Q.; Fox, A.; Wong, R.; Lee, M.; Moore, G.T.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Circulating tumor dna analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer

JAMA Oncology
2019 | Journal article
DOI: 10.1001/jamaoncol.2019.3616
EID:

2-s2.0-85073773804
Contributors: Tie, J.; Cohen, J.D.; Wang, Y.; Christie, M.; Simons, K.; Lee, M.; Wong, R.; Kosmider, S.; Ananda, S.; McKendrick, J. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Emerging strategies in the initial management of locally advanced rectal cancer

Future Oncology
2019 | Journal article
DOI: 10.2217/fon-2018-0941
EID:

2-s2.0-85071619549
Contributors: Gately, L.; Wong, H.-L.; Tie, J.; Wong, R.; Lee, M.; Lee, B.; Jalali, A.; Gibbs, P.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival

Asia-Pacific Journal of Clinical Oncology
2019 | Journal article
DOI: 10.1111/ajco.13135
EID:

2-s2.0-85061439509
Contributors: Mendis, S.; Beck, S.; Lee, B.; Lee, M.; Wong, R.; Kosmider, S.; Shapiro, J.; Yip, D.; Steel, S.; Nott, L. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: A prospective biomarker study

Gut
2019 | Journal article
DOI: 10.1136/gutjnl-2017-315852
EID:

2-s2.0-85047767738
Contributors: Tie, J.; Cohen, J.D.; Wang, Y.; Li, L.; Christie, M.; Simons, K.; Elsaleh, H.; Kosmider, S.; Wong, R.; Yip, D. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations

International Journal of Cancer
2019-07-15 | Journal article
DOI: 10.1002/ijc.32117
Contributors: Rachel Wong; Jeanne Tie; Margaret Lee; Joshua Cohen; Yuxuan Wang; Lu Li; Stephen Ma; Michael Christie; Suzanne Kosmider; Cristian Tomasetti et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

How accurate are medical oncologists’ impressions of management of metastatic colorectal cancer in Australia?

Asia-Pacific Journal of Clinical Oncology
2018 | Journal article
DOI: 10.1111/ajco.12671
EID:

2-s2.0-85015456215
Contributors: Au, L.; Turner, N.; Wong, H.-L.; Field, K.; Lee, B.; Boadle, D.; Cooray, P.; Karikios, D.; Kosmider, S.; Lipton, L. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Mismatch repair deficiency assessment by immunohistochemistry: For Lynch syndrome screening and beyond

Future Oncology
2018 | Journal article
DOI: 10.2217/fon-2018-0319
EID:

2-s2.0-85055596103
Contributors: Wong, H.-L.; Christie, M.; Gately, L.; Tie, J.; Lee, B.; Semira, C.; Lok, S.W.; Wong, R.; Gibbs, P.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Previous Bevacizumab and Efficacy of Later Anti–Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry

Clinical Colorectal Cancer
2018 | Journal article
DOI: 10.1016/j.clcc.2018.05.009
EID:

2-s2.0-85048992418
Contributors: Burge, M.; Semira, C.; Lee, B.; Lee, M.; Kosmider, S.; Wong, R.; Shapiro, J.; Ma, B.; Dean, A.P.; Zimet, A.S. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival

Clinical Colorectal Cancer
2018 | Journal article
DOI: 10.1016/j.clcc.2018.05.008
EID:

2-s2.0-85049331427
Contributors: Lee, M.M.; MacKinlay, A.; Semira, C.; Schieber, C.; Jimeno Yepes, A.J.; Lee, B.; Wong, R.; Hettiarachchige, C.K.H.; Gunn, N.; Tie, J. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

Acta Oncologica
2018 | Journal article
DOI: 10.1080/0284186X.2018.1487581
EID:

2-s2.0-85050571162
Contributors: Prasanna, T.; Karapetis, C.S.; Roder, D.; Tie, J.; Padbury, R.; Price, T.; Wong, R.; Shapiro, J.; Nott, L.; Lee, M. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

Future Oncology
2018-10-31 | Journal article
DOI: 10.2217/fon-2018-0668
Source: Self-asserted source
Rachel Wong
grade
Preferred source (of 2)‎

Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?

Internal Medicine Journal
2018-09-19 | Journal article
DOI: 10.1111/imj.14115
Part of ISSN: 1444-0903
Part of ISSN: 1445-5994
Source: Self-asserted source
Rachel Wong
grade
Preferred source (of 2)‎

Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma

Clinical Colorectal Cancer
2017 | Journal article
DOI: 10.1016/j.clcc.2016.09.011
EID:

2-s2.0-85006096665
Contributors: Tay, R.Y.; Jamnagerwalla, M.; Steel, M.; Wong, H.-L.; McKendrick, J.J.; Faragher, I.; Kosmider, S.; Hastie, I.; Desai, J.; Tacey, M. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study

Asia-Pacific Journal of Clinical Oncology
2017 | Journal article
DOI: 10.1111/ajco.12639
EID:

2-s2.0-85005784406
Contributors: Lee, B.; Wong, H.-L.; Tacey, M.; Tie, J.; Wong, R.; Lee, M.; Nott, L.; Shapiro, J.; Jennens, R.; Turner, N. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

Squamous cell carcinoma of unknown primary masquerading as multiple splenic abscesses

ANZ Journal of Surgery
2017-11-09 | Journal article
DOI: 10.1111/ans.14242
Source: Self-asserted source
Rachel Wong
grade
Preferred source (of 2)‎

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Science Translational Medicine
2016 | Journal article
DOI: 10.1126/scitranslmed.aaf6219
EID:

2-s2.0-84978062740
Contributors: Tie, J.; Wang, Y.; Tomasetti, C.; Li, L.; Springer, S.; Kinde, I.; Silliman, N.; Tacey, M.; Wong, H.-L.; Christie, M. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impact of primary tumor site on bevacizumab efficacy in metastatic colorectal cancer

Clinical Colorectal Cancer
2016 | Journal article
DOI: 10.1016/j.clcc.2016.02.007
EID:

2-s2.0-84960968937
Contributors: Wong, H.-L.; Lee, B.; Field, K.; Lomax, A.; Tacey, M.; Shapiro, J.; McKendrick, J.; Zimet, A.; Yip, D.; Nott, L. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impact of Surgical Complications Following Resection of Locally Advanced Rectal Adenocarcinoma on Adjuvant Chemotherapy Delivery and Survival Outcomes

Diseases of the Colon and Rectum
2016 | Journal article
DOI: 10.1097/DCR.0000000000000659
EID:

2-s2.0-84988354933
Contributors: Jamnagerwalla, M.; Tay, R.; Steel, M.; Keck, J.; Jones, I.; Faragher, I.; Gibbs, P.; Wong, R.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent

Clinical Colorectal Cancer
2016 | Journal article
DOI: 10.1016/j.clcc.2015.12.010
EID:

2-s2.0-84955326482
Contributors: Wong, S.F.; Wong, H.L.; Field, K.M.; Kosmider, S.; Tie, J.; Wong, R.; Tacey, M.; Shapiro, J.; Nott, L.; Richardson, G. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎

Survival impact of the Australian National Bowel Cancer Screening Programme

Internal Medicine Journal
2016 | Journal article
DOI: 10.1111/imj.12916
EID:

2-s2.0-84958780195
Contributors: Ananda, S.; Wong, H.; Faragher, I.; Jones, I.T.; Steele, M.; Kosmider, S.; Desai, J.; Tie, J.; Field, K.; Wong, R. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

Annals of Oncology
2015 | Journal article
DOI: 10.1093/annonc/mdv177
EID:

2-s2.0-84941630950
Contributors: Tie, J.; Kinde, I.; Wang, Y.; Wong, H.L.; Roebert, J.; Christie, M.; Tacey, M.; Wong, R.; Singh, M.; Karapetis, C.S. et al.
Source: Self-asserted source
Rachel Wong via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2
How many people are using ORCID?